IL1B, interleukin 1 beta, 3553

N. diseases: 1801; N. variants: 22
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.010 AlteredExpression disease BEFREE Plasma levels of the pro-inflammatory cytokines TNF-α and IL-1β were significantly increased in patients with AN, while the levels of prostaglandins PGE<sub>2</sub> (proinflammatory) and 15d-PGJ<sub>2</sub>, (anti-inflammatory) were lower compared with controls. 31398429 2020
CUI: C0009806
Disease: Constipation
Constipation
0.010 Biomarker phenotype BEFREE Our results suggest that neurotrophic factors and IL-1β are closely related to IBS-constipation and that decrease of ZO-1 is an important factor in female with IBS-diarrhea. 31623029 2020
CUI: C0011127
Disease: Pressure Ulcer
Pressure Ulcer
0.010 AlteredExpression disease BEFREE The infected and irradiated PUs exhibited a thinner neo-epidermis than those in the infected group, and the bacterial survival decreased in the laser group; the relative expression IL-1β mRNA levels demonstrated an increasing tendency while the relative expression IL-10 mRNA levels demonstrated a decreasing tendency in the infected + laser and laser groups. 31473868 2020
CUI: C0014335
Disease: Enteritis
Enteritis
0.010 AlteredExpression disease BEFREE The results showed that, compared with the control group, dietary CT (1) induced intestinal histopathological lesions and aggravated enteritis; (2) decreased the lysozyme and acid phosphatase activities, complement 3 (C3), C4 and immunoglobulin M contents, and down-regulated the Hepcidin, liver-expressed antimicrobial peptide(LEAP)-2A, LEAP-2B, Mucin2 and β-defensin-1 mRNA levels in the proximal intestine (PI), mid intestine (MI) and distal intestine (DI) (P < 0·05); (3) down-regulated the mRNA levels of anti-inflammatory cytokines transforming growth factor (TGF)-β1, TGF-β2 (not in MI and DI), IL-4/13A (not IL-4/13B), IL-10 and IL-11 partly correlated with target of rapamycin (TOR) signalling; (4) up-regulated the mRNA levels of pro-inflammatory cytokines interferon-γ2 (IFN-γ2), interleukin-1β (IL-1β), IL-6, IL-8 (not in PI), IL-12p35, IL-12p40, IL-15 and IL-17D partly related to nuclear factor kappa B (NF-κB) signalling in the intestine of on-growing grass carp. 31831090 2020
CUI: C0022729
Disease: Klebsiella Infections
Klebsiella Infections
0.010 AlteredExpression group BEFREE Elevated urinary IL-1β levels in multidrug resistant Escherichia coli and Klebsiella infections. 31820023 2020
CUI: C0024291
Disease: Lymphohistiocytosis, Hemophagocytic
Lymphohistiocytosis, Hemophagocytic
0.010 Biomarker disease BEFREE CD8+ T cells and the IL-33/ST2 axis remained essential mediators of disease; however, IFNγ-independent HLH immunopathology correlated with a 10-15-fold increase in neutrophilia (P < 0.001) and an altered cytokine milieu dominated by IL-6, IL-1β, and granulocyte-macrophage colony-stimulating factor (GM-CSF) (P < 0.05). 31400073 2020
CUI: C0025193
Disease: Melancholia
Melancholia
0.010 AlteredExpression disease BEFREE Patients with MDD with melancholic features showed higher IL-1β levels than those without melancholia. 31693974 2020
CUI: C0030848
Disease: Peyronie Disease
Peyronie Disease
0.010 Biomarker disease BEFREE In vitro model of PD was designed using experimental model of inflammation induced by Interleukin-1 (IL-1) in cultured fibroblasts and mechanical damage of the cells. 31733276 2020
CUI: C0032227
Disease: Pleural effusion disorder
Pleural effusion disorder
0.010 Biomarker group BEFREE IL-1β, HMGB1, HO-1, and LDH in the pleural effusions (PE) of patients with transudative, infectious, and malignant etiologies were determined using ELISA and enzymatic assays. 31639457 2020
CUI: C0034103
Disease: Pulpitis
Pulpitis
0.010 AlteredExpression disease BEFREE Immunohistochemistry was used to compare interleukin-1β (IL-1β) and osteocalcin (OCN) expression in the pulpitis model. 31419325 2020
CUI: C0262655
Disease: Recurrent urinary tract infection
Recurrent urinary tract infection
0.010 Biomarker disease BEFREE IL-1β has been implicated in the differentiation of symptomatic and asymptomatic urinary tract infections, but its role in MDR infections has not been elucidated. 31820023 2020
CUI: C0263725
Disease: Hemophilic arthropathy
Hemophilic arthropathy
0.010 Biomarker disease BEFREE The cascade starts with iron accumulation leading to an increase in CD<sup>68+</sup> and CD<sup>11b+</sup> cells responsible for initiating the inflammation.<b>Areas covered</b>: During inflammation, different factors and cytokines such as interleukin 1 (IL-1), IL-6, and tumor necrosis factor α (TNF-α) actively play parts in the pathogenesis of HA and also angiogenesis. 31657968 2020
CUI: C0264303
Disease: Laryngomalacia
Laryngomalacia
0.010 AlteredExpression disease BEFREE Presence and level of salivary pepsin was not significantly associated with need for surgical management, nor were the levels or presence of IL-1β or IL-8 significantly associated with presence or level of pepsin, diagnosis of laryngomalacia, or need for operative management. 31631681 2020
CUI: C0270850
Disease: Idiopathic generalized epilepsy
Idiopathic generalized epilepsy
0.010 Biomarker disease BEFREE <b>Background:</b> Neuroinflammation is an important feature of epileptogenesis.<b>Objectives:</b> To investigate the association of Interleukin-1beta-31 (IL-1β-31) and Interleukin-1 receptor antagonist (IL1-RA) genetic polymorphisms with idiopathic generalized epilepsy and demonstrate their influence on drug resistance in children.<b>Materials and Methods:</b> One hundred children with idiopathic generalized epilepsy were age and gender-matched with apparently healthy controls. 31698971 2020
CUI: C0277561
Disease: Juvenile disease
Juvenile disease
0.010 Biomarker disease BEFREE Response to IL-1 blockade was assessed by (1) clinical response (at least initial response compared to poor response), (2) switch to anti-IL-6 receptor therapy following IL-1 blockade or not (3) clinically inactive disease within 6 months of IL-1 blockade, (4) modified juvenile disease activity score and (5) reaching of a glucocorticoid free state. 31599092 2020
CUI: C0333519
Disease: Caries (morphologic abnormality)
Caries (morphologic abnormality)
0.010 Biomarker disease BEFREE This controlled split-mouth study aimed to estimate the effect of caries and related treatment on concentrations of interleukin (IL)-2, interferon (IFN)-γ, IL-12, IL-17A, IL-13, IL-10, IL-6, IL-5, IL-4, IL-22, tumor necrosis factor (TNF)-α, and IL1-β in gingival crevicular fluid (GCF) of caries affected teeth before (B), 7 (7D) and 30 (30D) days post-treatment and to compare them with concentrations from healthy teeth. 31791000 2020
CUI: C0399452
Disease: Supragingival dental plaque
Supragingival dental plaque
0.010 Biomarker disease BEFREE Subjective pain (assessed by visual analogue scale in pain diary and by chairside archwire activation), periodontal status (assessed by periodontal clinical parameters), cytokines in gingival crevicular fluid (interleukin 1β, prostaglandin E<sub>2</sub>, substance P) and periodontopathic bacteria (Porphyromonas gingivalis and Treponema denticola) in supragingival plaque were assessed. 31833004 2020
CUI: C0457950
Disease: Acute low back pain
Acute low back pain
0.010 Biomarker phenotype BEFREE To investigate the association between plasma levels of inflammatory cytokines (interleukin [IL]-1-β, IL-6, tumor necrosis factor [TNF]-α, and the soluble TNF receptor 1 [sTNF-R1]), disability, and risk of falls in older women with acute low back pain (LBP). 31606818 2020
CUI: C0687120
Disease: Nephronophthisis
Nephronophthisis
0.010 Biomarker disease BEFREE Herein, we show that the NF-κB signaling is active in Glis2 knockout kidney epithelial cells and that genetic inactivation of the toll-like receptor (TLR)/IL-1 receptor or pharmacologic elimination of senescent cells (senolytic therapy) reduces tubule damage, fibrosis, and apoptosis in the Glis2 mouse model of NPHP. 31676329 2020
CUI: C1306587
Disease: Acute encephalopathy
Acute encephalopathy
0.010 AlteredExpression disease BEFREE Cerebrospinal fluid levels of granzyme A were significantly higher, and those of TNF-α and IL-1RA were significantly lower in the AE group than in the cFS group; however, no significant differences in the levels of granzyme B, IFN-γ, IL-1β, IL-4, IL-6, IL-8, and IL-10 were observed between the 2 groups. 31709864 2020
CUI: C1701940
Disease: Pneumonia, Ventilator-Associated
Pneumonia, Ventilator-Associated
0.010 Biomarker disease BEFREE The VAPrapid2 trial aimed to determine whether measurement of bronchoalveolar lavage fluid IL-1β and IL-8 could effectively and safely improve antibiotic stewardship in patients with clinically suspected ventilator-associated pneumonia. 31810865 2020
CUI: C2718067
Disease: Alcoholic Steatohepatitis
Alcoholic Steatohepatitis
0.010 Biomarker disease BEFREE Deletion of GSDMD reduced IL-1β release and ameliorated alcoholic steatohepatitis in vivo. 31670032 2020
Nonrheumatic aortic (valve) stenosis
0.010 AlteredExpression disease BEFREE Peripheral blood IL-1 family mRNA and protein levels in NR-AS patients and healthy adults were quantified by real-time quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay. 31416779 2020
CUI: C3714753
Disease: RETINOSCHISIS 1, X-LINKED, JUVENILE
RETINOSCHISIS 1, X-LINKED, JUVENILE
0.010 AlteredExpression disease BEFREE RA+RS signifificantly decreased the diastolic blood pressure, renal vascular resistance index, and parenchymal thickness, increased 24 h urinary volume as well as lowered the levels of urine mALB and serum cystatin ^C, IL-1β and β2-Mg of SHRs (P <0.05 vs. SHRs). 31388973 2020
CUI: C0001306
Disease: Acute alcoholic liver disease
Acute alcoholic liver disease
0.010 Biomarker disease BEFREE Proinflammatory cytokine expression, including IL-1β and IL-23, was also higher than in healthy controls, but both classical (CD14<sup>++</sup>CD16<sup>-</sup>) and intermediate monocytes in AH were refractory to TLR stimulation. 31722987 2019